An optimum prophylactic dose of prasugrel monotherapy may safely and effectively prevent the development of experimental thrombotic strokes
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2015
has subject area
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Piperazines (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Prasugrel Hydrochloride (MeSH)
- Stroke (MeSH)
- Thiophenes (MeSH)
- Ticlopidine (MeSH)
published in
- Thrombosis Research Journal